Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer
Phase III
· Site: SITE001 (USA) (Dr. Reyes)
· consented 2023-02-23
Adverse events
4
Serious AEs
2
Open data queries
0
Luna dropout signal
–
Adverse events
severe
serious
assessed
2026-08-18
Grade 4 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-09-16 (study day 191); relationship: N; serious criteria: life-threatening
mild
assessed
2026-08-18
Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-12-27 (study day 293); relationship: not assessed
severe
serious
assessed
2026-08-18
Grade 3 Alopecia — outcome: RECOVERED/RESOLVED; onset 2024-01-08 (study day 305); relationship: not assessed; serious criteria: hospitalization
moderate
assessed
2026-08-18
Grade 2 Dyspnoea — outcome: UNKNOWN; onset 2024-03-24 (study day 381); relationship: not assessed
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.